Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS), a common endocrinopathy of women of reproductive age, is associated with the early appearance of multiple risk factors for cardiovascular disease, such as abdominal obesity, dyslipidemia, and diabetes mellitus. However, premature atherosclerosis of the carotid artery has not yet been demonstrated in young women with PCOS. Measurement of carotid intima-media thickness (IMT) is considered an easy and reliable index of subclinical atherosclerosis, which is predictive of subsequent myocardial infarction and stroke. To evaluate the cardiovascular risk of PCOS and the participation of the hyperandrogenemic and metabolic pattern, we measured carotid IMT by B-mode ultrasound as well as hormonal and several cardiovascular disease-associated parameters in 75 young women with PCOS and 55 healthy, age- and body mass index-matched women. The PCOS women had significantly increased carotid IMT (0.58 vs. 0.47 mm, P < 0.001) and abdominal adiposity; higher levels of androgens, insulin, homeostasis model assessment score of insulin sensitivity, and total and low-density lipoprotein-cholesterol; and significantly lower levels of SHBG and high-density lipoprotein-cholesterol. In the studied population (n = 130), PCOS status, age, body mass index, and parental history of coronary heart disease were strong positive predictors of carotid IMT, whereas dehydroepiandrosterone sulfate was a strong negative predictor. In PCOS patients lower delta4-androstenedione and high-density lipoprotein-cholesterol levels were additionally strong positive predictors of carotid IMT, whereas in control women only total cholesterol was the additional positive predictor of carotid IMT. In conclusion, young women with PCOS have an early increase of cardiovascular risk factors and greater carotid IMT, both of which may be responsible for subclinical atherosclerosis. The hyperandrogenemic phenotype of the syndrome may attenuate the consequences of the dysmetabolic phenotype on the vascular wall.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Young women and adolescents with PCOS have been shown to have early atherosclerotic CVD, including increased carotid intimal medial thickness and carotid plaque.86, 87, 88, 89”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [87]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Bots, M. L., Hoes, A. W., Koudstaal, P. J., Hofman, A., & Grobbee, D. E. (1997) · Circulation · doi:10.1161/01.cir.96.5.1432 · Cited by 2,345
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,155
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
Cited by
Items 101–170 of 170
Is the Risk for Cardiovascular Disease Increased in all Phenotypes of the Polycystic Ovary Syndrome?
Daskalopoulos, G. N., Karkanaki, A., Karagiannis, A. I., Mikhailidis, D. P., & Athyros, V. G. (2011) · Angiology · doi:10.1177/0003319711399571 · Cited by 10
Ilie, I. R. P., Pepene, C. E., Duncea, I., & Ilie, R. (2008) · Open Medicine · doi:10.2478/s11536-008-0044-8 · Cited by 11
Aihaiti, R., Shen, Z., Wu, X., & Niu, Z. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.07.017 · Cited by 12
Wu, X., Wilke, M., Batara, J., Proctor, S. D., Cree‐Green, M., Ghosh, M., Raggi, P., Windram, J. D., Becher, H. H., & Vine, D. F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520922 · Cited by 10
Treatment for polycystic ovary syndrome: a critical appraisal of treatment options
Nader, S. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.3.349 · Cited by 9
Obesity, metabolic syndrome, and disorders of energy balance
Weiss, R., & Lustig, R. H. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00031-7 · Cited by 14
Teng, H., Chien, Y., Hsu, M.-I., & Chen, C.-I. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.736553 · Cited by 10
Aldrighi, J. M., Tsutsui, J. M., Kowastch, I., Ribeiro, A. L., Scapinelli, A., Tamanaha, S., de Oliveira, R. M., & Mathias, W. (2014) · Echocardiography · doi:10.1111/echo.12849 · Cited by 10
Polycystic ovary syndrome as a developmental disorder
Goverde, A. J., Westerveld, H. E., Verhulst, S. M., & Fauser, B. C. (2008) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.3.6.775 · Cited by 8
Dharmalingam, M., Garg, N., Prabhu, V. M. D., & Murthy, N. S. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.190552 · Cited by 8
Bahat, P. Y., Özel, A., & Demirci, A. (2021) · Cureus · doi:10.7759/cureus.13025 · Cited by 9
de Medeiros, S. F., Barbosa, B. B., de Medeiros, M. A. S., Yamamoto, A. K. L. W., & Yamamoto, M. M. W. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1741030 · Cited by 11
Relationship between TSH, T4, T3 and Prolactin in overweight and lean Sudanese PCOS Patients
Abdelsalam, K. E. A., & Ibrahim, W. (2015) · International Journal of Biomedical Research · doi:10.7439/ijbr.v6i2.1671 · Cited by 12
Cardiovascular risk factors in healthy women with previous small for gestational age infants
Paradisi, G., Mattoli, M. V., Tomei, C., Zuppi, C., Lulli, P., Quagliozzi, L., & Caruso, A. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2011.01547.x · Cited by 7
Obesity in pregnancy as a model to identify women at risk for later metabolic syndrome
Neri, C., Cesare, C. D., Labianca, A., Viggiano, M., Caruso, A., & Paradisi, G. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1342792 · Cited by 7
Dmitrović, R., & Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_11 · Cited by 7
Loverro, G., Pergola, G. D., Naro, E. D., Tartagni, M., Lavopa, C., & Caringella, A. M. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-25 · Cited by 10
Vine, D. F., Proctor, E., Weaver, O. R., Ghosh, M., Maximova, K., & Proctor, S. D. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab114 · Cited by 11
Das polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · doi:10.1007/s00108-006-1776-7 · Cited by 9
Thyroid Disorders in Women with Polycystic Ovary Syndrome
Pervin, H. H., Kazal, R. K., Rahman, A. K. M. S., Pervin, T., Fatema, K., Chowdhury, S. A., Mamun-Ar-Rashid, S. K., & Mahjabeen, S. (2020) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2020.84012 · Cited by 12
A Canary in the Coal Mine: Reproductive Health and Cardiovascular Disease in Women
Quinn, M. M., & Cedars, M. I. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603097 · Cited by 5
Xie, N., & Zhao, W. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1656389 · Cited by 7
Aminbakhsh, A., Théberge, E. T., Burden, E., Adejumo, C. K., Gravely, A., Lehman, A., & Sedlak, T. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1502985 · Cited by 5
Role of hyperinsulinemic insulin resistance in polycystic ovary syndrome
Iuorno, M. J. (2001) · Polycystic Ovary Syndrome · doi:10.1017/cbo9780511545191.013 · Cited by 3
Geronikolou, S. A., Bacopoulou, F., Chryssanthopoulos, S., Cokkinos, D. V., & Chrousos, G. P. (2022) · Children · doi:10.3390/children9030316 · Cited by 5
Reyna‐Villasmil, E., Mejía-Montilla, J., Torres-Cepeda, D., Santos-Bolívar, J., Aragon-Charrys, J., Reyna-Villasmil, N., & Bravo-Henríquez, A. (2012) · Progresos de Obstetricia y Ginecología · doi:10.1016/j.pog.2011.10.005 · Cited by 3
Diagnosis and Treatment of Dyslipoproteinemias in Children and Adolescents
Kwiterovich, P. O., & Byrne, K. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_30 · Cited by 3
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_8 · Cited by 4
Meyer, M. L., Tepper, P. G., Barinas‐Mitchell, E., Korytkowski, M. T., & Talbott, E. O. (2015) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22280 · Cited by 3
Leuștean, L., Dimitriu, C., Fica, S. V., Ungureanu, M.-C., Preda, C., Mogoş, V., Ungureanu, D. A., & Vulpoi, C. (2015) · Revista română de medicină de laborator · doi:10.1515/rrlm-2015-0010 · Cited by 3
Sex and Gender Specific Aspects—From Cells to Cardiovascular Disease
Regitz‐Zagrosek, V. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00008-5 · Cited by 2
Das polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · Cited by 2
Cardiovascular Disease and Inflammation
Orio, F., Diamanti‐Kandarakis, E., & Palomba, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_13 · Cited by 2
Kahal, H. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Das polyzystische Ovarsyndrom – Metabolische Konsequenzen
Tan, S., Hahn, S., & Janssen, O. E. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111466 · Cited by 1
Prasad, N. R., Bitla, A. R. R., Suchitra, M. M., Gopal, G. R., Sachan, A., & Rao, P. (2014) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0188-1 · Cited by 1
Non-expression of androgen receptors in the carotid intimal medial zone
Ogeng’o, J. A., Ongeti, K. W., & Saidi, H. (2012) · Cited by 1
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_3 · Cited by 1
Evaluation and Management of Dyslipidemia in Children and Adolescents
Nagy, C. D., & Kwiterovich, P. O. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00012-3 · Cited by 1
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.37 · Cited by 7
Polycystic Ovary Syndrome and Metabolic Syndrome
Pesant, M.-H., & Baillargeon, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_14 · Cited by 1
Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_25 · Cited by 3
Haydardedeoğlu, F. E., Haydardedeoğlu, B., Kozanoğlu, İ., Tutuncu, N., Anaforoğlu, İ., & Ertörer, M. E. (2014) · IVF Lite · doi:10.4103/2348-2907.140126 · Cited by 1
Detection and Treatment of Children and Adolescents with Dyslipidemia
Kwiterovich, P. O. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_5 · Cited by 1
[The polycystic ovary syndrome. The point of view of the internist].
Rodríguez-Flores, M. (2011) · PubMed · Cited by 3
Polycystic Ovary Syndrome-Related Risks in Postmenopausal Women
Anagnostis, P. G., Paschou, S. Α., Lambrinoudaki, I. V., & Goulis, D. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_16 · Cited by 1
Marcadores precoces de doença cardiovascular em mulheres com síndrome dos ovários policísticos
Soares, G. M. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2008.tde-26092013-164044 · Cited by 1
Wild, R. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.09.013 · Cited by 1
The Clinical Use of Noninvasive Modalities in the Assessment of Atherosclerosis
Chugh, A. R., PATEL, S. N., Rajaram, V., Neems, R., Feinstein, M. J., Goldin, M. D., & Feinstein, S. B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_18 · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Markers for Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome and Controls
Meyer, M. L. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Polycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519
Gonçalves, M. A. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2007.tde-13022008-101611
Insulin Action and Secretion in Polycystic Ovary Syndrome
Warren-Ulanch, J., & Arslanian, S. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_11
Metabolic Complications of Polycystic Ovary Syndrome
Setji, T. L., & Brown, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_23 · Cited by 1
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Memu, A. R., Zosin, I., & Negrişanu, G. (2013) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2013-0015
Dagre, A. G., Lekakis, J., Mihas, C. C., Protogerou, A. D., Thalassinou, L., Tryfonopoulos, D. J., Douridas, G., Papamichael, C. M., & Alevizaki, M. K. (2011)
Metabolic Aspects of Polycystic Ovary Syndrome
Svacina, S. (2015) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000471434.20331.09
Rodríguez-Flores, M. (2011)
Genome-Wide Association Studies of Ovarian Function Disorders
Leung, C., Zhao, H., Lv, Y., Lu, G., & Chen, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00019-4
Rojas, J., Chávez-Castillo, M., Olivar, L. C., & Bermúdez, V. (2013) · Revista Latinoamericana de Hipertensión/Revista Latinoamericana de Hipertensiòn
Zhuang, C., Wang, Q., Wang, W.-J., Sun, R., Zhang, X., & Yu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-230193/v1
Polycystic Ovary Syndrome and Metabolic Syndrome
Carreau, A., Pesant, M.-H., & Baillargeon, J. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_16
Recuero, A. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-19072022-163406
Sydora, B. C., Ghosh, M., Chambers, S., Haase, A., Davenport, M. H., Beaulieu, C., Thompson, R. B., Windram, J., Becher, H., Raggi, P., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-124025
Cardiovascular disease among diabetic women with bilateral oophorectomy.
Appiah, D. (2013) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/43
Metadata
- Authors
- Vryonidou, A., Papatheodorou, A., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou-Asteriou, A.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Democritus University of Thrace (GR)
- Hellenic Red Cross (GR)
- Corresponding author
- Vryonidou, Andromachi
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05
- Volume
- 90
- Issue
- 5
- Pages
- 2740-2746
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1974985058
- Cited by
- 171
- References
- 74
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 5 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 7
- FWCI
- 17.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- polycystic ovary syndrome, carotid intima-media thickness, subclinical atherosclerosis, hyperandrogenism, cardiovascular risk, young women, abdominal fat, insulin resistance, androgens, dehydroepiandrosterone sulfate, Δ4-androstenedione, HDL cholesterol, LDL cholesterol, sex hormone-binding globulin, dyslipidemia
- MeSH terms
- Adolescent, Adult, Carotid Arteries, Female, Humans, Phenotype, Polycystic Ovary Syndrome, Prospective Studies, Body Mass Index, Multivariate Analysis, Tunica Intima, Hyperandrogenism, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.